AAC
Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Okuda, D.
Right arrow Articles by Nagaoka, I.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Okuda, D.
Right arrow Articles by Nagaoka, I.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, August 2006, p. 2602-2607, Vol. 50, No. 8
0066-4804/06/$08.00+0     doi:10.1128/AAC.00331-06
Copyright © 2006, American Society for Microbiology. All Rights Reserved.

Determination of the Antibacterial and Lipopolysaccharide-Neutralizing Regions of Guinea Pig Neutrophil Cathelicidin Peptide CAP11

Daiju Okuda,1 Shin Yomogida,1 Hiroshi Tamura,2 and Isao Nagaoka1*

Department of Host Defense and Biochemical Research, Juntendo University School of Medicine, Tokyo 113-8421, Japan,1 Seikagaku Corporation, Tokyo 100-0005, Japan2

Received 17 March 2006/ Returned for modification 11 May 2006/ Accepted 23 May 2006

Previously, we revealed that a cationic antibacterial polypeptide of 11 kDa (CAP11), a member of the cathelicidins isolated from guinea pig neutrophils, exhibits not only potent antibacterial activity but also lipopolysaccharide (LPS)-neutralizing activity. In this study, to determine the biologically active regions of CAP11, we isolated or synthesized the partial peptides of CAP11 and evaluated their antibacterial and LPS-neutralizing activities. Although CAP11 has a unique homodimeric structure with a disulfide bridge, the biological activities of dimeric and monomeric forms of CAP11 were almost the same. Moreover, the G1-E33 peptide of CAP11 showed the same activities as CAP11, whereas the C-terminal region (Y34 to I43) possessed no biological activities. In addition, the three 18-mer peptides (G1-R18, T9-K26, and L16-E33) with overlapping sequences were synthesized, and their activities were determined. The three 18-mer peptides retained the antibacterial activities, and G1-R18 was the most potent. In contrast, the LPS-neutralizing activities of these peptides were markedly reduced. Together, these observations indicate that the active region with antibacterial activity is localized at G1 to R18 of CAP11, whereas longer sequences (such as G1 to E33) would be required for the expression of LPS-neutralizing activity. Furthermore, the C-terminal region (Y34 to I43) and a disulfide bridge are not essential for the antibacterial and LPS-neutralizing activities of CAP11.


* Corresponding author. Mailing address: Department of Host Defense and Biochemical Research, Juntendo University School of Medicine, 2-1-1 Hongo, Bunkyo-ku, Tokyo 113-8421, Japan. Phone: 81-3-5802-1033. Fax: 81-3-3813-3157. E-mail: nagaokai{at}med.juntendo.ac.jp.


Antimicrobial Agents and Chemotherapy, August 2006, p. 2602-2607, Vol. 50, No. 8
0066-4804/06/$08.00+0     doi:10.1128/AAC.00331-06
Copyright © 2006, American Society for Microbiology. All Rights Reserved.




This article has been cited by other articles:




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
Clin. Vaccine Immunol. Clin. Microbiol. Rev.
J. Clin. Microbiol. ALL ASM JOURNALS

Copyright © 2006 by the American Society for Microbiology. All rights reserved.